These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37104903)

  • 81. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
    Lainé AL; Price D; Davis J; Roberts D; Hudson R; Back K; Bungay P; Flanagan N
    Int J Pharm; 2016 Oct; 512(1):118-125. PubMed ID: 27543354
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent.
    Yang Q; Zu C; Li W; Wu W; Ge Y; Wang L; Wang L; Li Y; Zhao X
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105832
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Spray dried solid dispersion of repaglinide using hypromellose acetate succinate:
    Surti N; Mahajan AN; Patel D; Patel A; Surti Z
    Drug Dev Ind Pharm; 2020 Oct; 46(10):1622-1631. PubMed ID: 32816575
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.
    He X; Pei L; Tong HH; Zheng Y
    AAPS PharmSciTech; 2011 Mar; 12(1):104-13. PubMed ID: 21181514
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.
    Liu QY; Zhang ZH; Jin X; Jiang YR; Jia XB
    J Pharm Pharmacol; 2013 Jun; 65(6):839-46. PubMed ID: 23647677
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.
    Hou P; Ni J; Cao S; Lei H; Cai Z; Zhang T; Yu F; Tan Q
    AAPS PharmSciTech; 2013 Jun; 14(2):629-38. PubMed ID: 23636816
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
    Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
    Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M; Hu J; Gao P; Li L; Ali-Reynolds A; Chal B; Gupta V; Ma C; Mahajan N; Akrami A; Surapaneni S
    Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and
    Dong CL; Zheng SD; Liu YY; Cui WQ; Hao MQ; God'spower BO; Chen XY; Li YH
    Pharm Dev Technol; 2020 Nov; 25(9):1043-1052. PubMed ID: 32546042
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide.
    Fathanah A; Setyawan D; Sari R
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837256
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Precipitation from amorphous solid dispersions in biorelevant dissolution testing: The polymorphism of regorafenib.
    Müller M; Platten F; Dulle M; Fischer B; Hoheisel W; Serno P; Egelhaaf S; Breitkreutz J
    Int J Pharm; 2021 Jun; 603():120716. PubMed ID: 34015382
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
    Zhang F; Mao J; Tian G; Jiang H; Jin Q
    AAPS PharmSciTech; 2022 Jan; 23(1):65. PubMed ID: 35102461
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability.
    Kim SJ; Lee HK; Na YG; Bang KH; Lee HJ; Wang M; Huh HW; Cho CW
    Int J Pharm; 2019 Jan; 555():11-18. PubMed ID: 30448313
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability.
    Yang L; Wu P; Xu J; Xie D; Wang Z; Wang Q; Chen Y; Li CH; Zhang J; Chen H; Quan G
    AAPS PharmSciTech; 2021 Apr; 22(4):142. PubMed ID: 33893566
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use.
    Jachowicz R; Czech A
    Pharm Dev Technol; 2008; 13(6):495-504. PubMed ID: 18720246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.